Search Results

Filter
  • 1-10 of  231,869 results for ""Azathioprine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis.

  • Authors : Lee YH; Department of Rheumatology, Korea University Anam Hospital, Korea University College of Medicine, 73, Inchon-ro, 136-705, Seoul, Seongbuk-gu, Korea (Republic of). .; Song GG

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/diagnosis ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/drug therapy

  • Source: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Feb; Vol. 83 (Suppl 1), pp. 140-147. Date of Electronic Publication: 2023 Jun 06.Publisher: Springer Country of Publication: Germany NLM ID: 0414162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-1250

Record details

×
Academic Journal

Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort study.

  • Authors : San Martin DL; Postgraduate Program in Health Sciences, Federal University of Bahia, Salvador, Brazil 40026-010. Electronic address: .; Fukuda TG

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Neuromyelitis Optica*; Humans

  • Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Mar; Vol. 83, pp. 105452. Date of Electronic Publication: 2024 Jan 18.Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mycophenolate and azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Azathioprine*/Azathioprine*/Azathioprine*/pharmacology ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/diagnosis

  • Source: BMJ open respiratory research [BMJ Open Respir Res] 2024 Feb 27; Vol. 11 (1). Date of Electronic Publication: 2024 Feb 27.Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Commentary: Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.

  • Authors : Mittal M; Department of Endocrinology and Metabolism, All India Institute of Medical Sciences Jodhpur, Jodhpur, Rajasthan, India.; Rizvi A

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Graves Disease*/Graves Disease*/Graves Disease*/drug therapy; Humans

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Feb 21; Vol. 15, pp. 1342915. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

×
Academic Journal

Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors.

  • Authors : Ueda H; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Narumi K

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Drug-Related Side Effects and Adverse Reactions*; Humans

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jan; Vol. 23 (1), pp. 89-97. Date of Electronic Publication: 2023 Dec 18.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Myasthenia Gravis*/Myasthenia Gravis*/Myasthenia Gravis*/drug therapy ; Mycophenolic Acid*/Mycophenolic Acid*/Mycophenolic Acid*/adverse effects

  • Source: The Lancet. Neurology [Lancet Neurol] 2024 Mar; Vol. 23 (3), pp. 267-276.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465

Record details

×
Academic Journal

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/drug therapy; Humans

  • Source: Journal of hepatology [J Hepatol] 2024 Apr; Vol. 80 (4), pp. 576-585. Date of Electronic Publication: 2023 Dec 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical characteristics, diagnosis and management of Sweet syndrome induced by azathioprine.

  • Authors : Fan Z; Department of Pharmacy, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, Hunan, China.; College of Pharmacy, Changsha Medical University, Changsha, 410219, Hunan, China.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Sweet Syndrome*/Sweet Syndrome*/Sweet Syndrome*/chemically induced ; Sweet Syndrome*/Sweet Syndrome*/Sweet Syndrome*/diagnosis

  • Source: Clinical and experimental medicine [Clin Exp Med] 2023 Nov; Vol. 23 (7), pp. 3581-3587. Date of Electronic Publication: 2023 Jul 11.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.

  • Authors : Su J; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.; Xu M

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Prednisone*/Prednisone*/Prednisone*/adverse effects ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2196864.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

Record details

×
Academic Journal

Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy; Humans Thiopurine S methyltranferase deficiency

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Dec; Vol. 168, pp. 115706. Date of Electronic Publication: 2023 Oct 17.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  231,869 results for ""Azathioprine""